
1. BMC Infect Dis. 2020 Jul 11;20(1):498. doi: 10.1186/s12879-020-05204-2.

Yersinia enterocolitica biotype 1B case report: an unusual pathogen in an
osteoarticular infection on device.

Wallet F(1)(2), Le Guern AS(3), Penven M(1)(2), Senneville E(4)(5)(6), Savin
C(3), Loïez C(7)(8)(9).

Author information: 
(1)CHU Lille, F 59000, Lille, France.
(2)Laboratoire de Bactériologie - Institut de Microbiologie, Centre de Biologie
Pathologie, F-59037, Lille Cedex, France.
(3)Unité de Recherche Yersinia / Centre National de Référence de la peste et
autres yersinioses, Institut Pasteur, F75015, Paris, France.
(4)CH Tourcoing, F 59200, Tourcoing, France.
(5)Univ. Lille, F59000, Lille, France.
(6)Centre de Référence des Infections Ostéo-Articulaires Complexes Nord-Ouest
(CRIOAC-NO) Lille, Tourcoing, France.
(7)CHU Lille, F 59000, Lille, France. caroline.loiez@chru-lille.fr.
(8)Laboratoire de Bactériologie - Institut de Microbiologie, Centre de Biologie
Pathologie, F-59037, Lille Cedex, France. caroline.loiez@chru-lille.fr.
(9)Centre de Référence des Infections Ostéo-Articulaires Complexes Nord-Ouest
(CRIOAC-NO) Lille, Tourcoing, France. caroline.loiez@chru-lille.fr.

BACKGROUND: Yersinia enterocolitica is an aero-anaerobic Gram-negative
coccobacilli of the Enterobacteriaceae family, rarely reported in osteoarticular 
infection.
CASE PRESENTATION: This report case described a rare septic osteoarticular
infection on device due to Yersinia enterocolitica biotype 1B. A purulent fistula
appeared after osteosynthesis with plate performed abroad 27 days prior to the
presentation for a distal femoral fracture. The treatment consisted of surgical
irrigation and washing of the femoral plate and a bitherapy by levoflaxacine and 
ceftriaxone during 3 months.
CONCLUSION: Y. enterocolitica biotype 1B is extremely rare in France. Moreover,
the strain implicated in this european case is extremely close from the USA
reference strain (with only 2 SNP difference) described in a septicemia in Ohio. 
The extreme proximity of the strains underlines the need for a sustained
surveillance of the spread of this pathogen in France.

DOI: 10.1186/s12879-020-05204-2 
PMCID: PMC7353708
PMID: 32652941  [Indexed for MEDLINE]

